Elutia (ELUT) vs iTonic (ITOC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Elutia (ELUT) has outperformed iTonic (ITOC) over the past year, losing 6.9% versus a loss of 64.2%. Elutia is the larger company by market cap ($35.0 million vs $29.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELUT | ITOC |
|---|---|---|
| Share price | $0.7905 | $4.09 |
| Market cap | $35.01M | $29.92M |
| 1-day change | -4.45% | +1.77% |
| YTD return | +19.38% | -40.32% |
| 1-year return | -6.94% | -64.16% |
| 5-year return | -84.82% | — |
| EPS (TTM) | $-0.64 | $-4.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.39 | $18.40 |
| 52-week low | $0.50 | $3.42 |
| Distance from 52-week high | -42.92% | -77.77% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +532.51% | — |
| Average volume | 185.82K | 50.95K |
| Shares outstanding | 44.29M | 6.84M |
| Employees | 25 | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELUT has outperformed ITOC by 57.2 percentage points over the past year.
About Elutia
ELUT stock →Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 25 employees
About iTonic
ITOC stock →iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 7 employees
ELUT vs ITOC FAQ
Which is bigger, Elutia or iTonic?
Elutia (ELUT) is larger, with a market capitalization of $35.01M compared with $29.92M for iTonic (ITOC).
Which stock has performed better over the past year, ELUT or ITOC?
ELUT returned -6.94% over the past 12 months, compared with -64.16% for ITOC (price return, excluding dividends). Past performance does not predict future results.
Are Elutia and iTonic in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for Elutia and Biotechnology: Electromedical & Electrotherapeutic Apparatus for iTonic.